ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $115,388 | -64.3% | 10,386 | +45.4% | 0.00% | – |
| Q4 2022 | $323,620 | +7.2% | 7,144 | +24.4% | 0.00% | – |
| Q3 2022 | $302,000 | -68.2% | 5,742 | -71.2% | 0.00% | -100.0% |
| Q2 2022 | $950,000 | -35.4% | 19,972 | -1.7% | 0.00% | -50.0% |
| Q1 2022 | $1,471,000 | +18.1% | 20,324 | +17.7% | 0.00% | +100.0% |
| Q4 2021 | $1,246,000 | +83.0% | 17,269 | +45.1% | 0.00% | 0.0% |
| Q3 2021 | $681,000 | +28.7% | 11,904 | -0.0% | 0.00% | 0.0% |
| Q2 2021 | $529,000 | +142.7% | 11,906 | +126.0% | 0.00% | – |
| Q4 2020 | $218,000 | -8.4% | 5,269 | +0.6% | 0.00% | – |
| Q3 2020 | $238,000 | -76.6% | 5,236 | -74.2% | 0.00% | -100.0% |
| Q2 2020 | $1,019,000 | +11.5% | 20,295 | +37.7% | 0.00% | 0.0% |
| Q4 2019 | $914,000 | – | 14,740 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |